Key Takeaways Hologic's data reveals rising rates of women screened for blood pressure, cancer and diabetes.Hologic finds STI testing stagnant at 10%, with no improvement in five years.Hologic expands molecular diagnostics with Aptima tests for STIs and HPV.Hologic’s (HOLX) fifth edition of the Global Women’s Health Index highlights a persistent screening gap for key preventable conditions. Developed in partnership with Gallup, the Index tracks progress in women’s health and well-being worldwide, based on a ...